The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease

Q Shen, M Yang, S Wang, X Chen, S Chen… - Frontiers in …, 2024 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic syndrome characterized by
excessive fat deposition in hepatocytes and a major cause of end-stage liver disease …

Cryptotanshinone alleviates liver fibrosis via inhibiting STAT3/CPT1A-dependent fatty acid oxidation in hepatic stellate cells

Z Li, Y Zheng, L Zhang, E Xu - Chemico-Biological Interactions, 2024 - Elsevier
Hepatic stellate cells (HSCs) are a major source of fibrogenic cells and play a central role in
liver fibrogenesis. HSC activation depends on metabolic activation, for which it is well …

Dual-ligand-functionalized nanostructured lipid carriers as a novel dehydrocavidine delivery system for liver fibrosis therapy

X Su, H Zhong, Y Zeng, Y Zhang, B Zhang… - Colloids and Surfaces B …, 2025 - Elsevier
Background Liver fibrosis is a common stage of various chronic liver diseases, often
developing into liver cirrhosis, and even liver cancer. Activated hepatic stellate cells …

Human placental mesenchymal stromal cells promote the formation of CD8+ CD122+ PD-1+ Tregs via CD73/Foxo1 to alleviate liver injury in graft-versus-host disease …

Y Zhao, Z Chen, Y Wu, J Zhang, H Zhang, K Han… - International …, 2024 - Elsevier
Background Human placental mesenchymal stromal cells (hPMSCs) are known to limit graft-
versus-host disease (GVHD). CD8+ CD122+ PD-1+ Tregs have been shown to improve the …